Nalaganje...
Isocitrate Dehydrogenase (IDH)1/2 Mutations as Prognostic Markers in Patients With Glioblastomas
The purpose of this study was to perform a meta-analysis examining the association of isocitrate dehydrogenase (IDH)1/2 mutations with overall survival (OS) and progression-free survival (PFS) in patients with glioblastomas. Medline, Cochrane, EMBASE, and Google Scholar were searched from inception...
Shranjeno v:
| izdano v: | Medicine (Baltimore) |
|---|---|
| Main Authors: | , , , |
| Format: | Artigo |
| Jezik: | Inglês |
| Izdano: |
Wolters Kluwer Health
2016
|
| Teme: | |
| Online dostop: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4782833/ https://ncbi.nlm.nih.gov/pubmed/26945349 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1097/MD.0000000000002583 |
| Oznake: |
Označite
Brez oznak, prvi označite!
|